Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Clinical trial NCT06713434 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06713434
Sponsor: Fundación DEBRA Chile, Niños Piel de Cristal
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Junctional Epidermolysis Bullosa Epidermolysis Bullosa (EB)Dystrophic Epidermolysis Bullosa Recessive Dystrophic Epidermolysis Bullosa

Start date: 2024-05-07
Primary completion: 2026-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.